Genomic Subtyping Could Guide Treatment Decisions for Bladder Cancer Data source: Bryant Furlow, Cancer Network Genomic subtyping of muscle-invasive bladder cancer could inform decisions on when best to use neoadjuvant cisplatin-based chemotherapy (NAC), according to a retrospective, non-randomized study presented (abstract 281) at the 2017 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium Different molecular muscle-invasive bladder cancer subtypes … Read More